Latest news for Proteome Sciences (OTC:PMSNF) Stock

Proteome Sciences PLC is protein biomarker research and development. provider of contract research services for the identification, validation and application of protein biomarkers. Its only reportable segment is the sale of goods and biomarker services. It generates maximum revenue from the TMT product and end customer sales-based royalties. Geographically, it has a presence in the United States, the United Kingdom, the European Union, and Other.

News

Intraday Update

Markets

Movers

Trading Ideas

ALVVF

APPS

APRO

ATEC

AURI

AVXT

BBBXF

BLHEY

BMCH

CBOE

CETV

CHPGF

CINF

CLSI

CMXC

CNMD

COLD

CONC

CUBE

CVNA

CYRX

DPMLF

EVRG

FERN

GMAB

GNMSF

GOLD

GRWG

HLND

IMOS

ITMC

MIRM

MISVF

MXSG

Nuveen Insured Tax-Free Advantage Municipal Fund

Nuveen Insured New York Tax-Free Advantage Municipal Fund

NSRGF

Nestle Sponsored representing Registered Shares Series B

NSRGY

Nuveen Insured Dividend Advantage Municipal Fund

Nuveen New Jersey Dividend Advantage Municipal Fund

Nuveen Dividend Advantage Municipal Fund 3

ORZCF

PERI

PFGC

PMSNF

PODD

PRNB

RGLD

RNSGF

ROGFF

ROKU

SEDG

SLVRF

SWCH

TCEGF

TMCX

TNAV

TORXF

TRXD

WELL

WKLDF

PSTO

CSPCY

TRZBF

SILV

Stocks That Hit 52-Week Highs Of Monday

PROTEOME SCIENCES PLC by Proteome Sciences PLC

Proteome Sciences PLC

Proteome Sciences

Comments

Proteome Sciences

News

Latest news for Proteome Sciences (OTC:PMSNF) Stock

Monday, August 12, 2019

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga